Linnaeus Therapeutics, Inc.

Amendment
CIK: 0001752026·Biotechnology·DELAWARE·Filed: Dec 26, 2024
Total Offering

$6,860,000

Amount Sold

$5,824,155

Investors

12

First Sale

Aug 12, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b), Section 4(a)(5)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Patrick T. Mooney
Related Person
Todd T. Thomson
Related Person
James Demetriades
Related Person
Michael D. Poisel
Related Person
Chris Arendt
Related Person

Company

Linnaeus Therapeutics, Inc.

30 WASHINGTON AVENUE, SUITE F

HADDONFIELD, NJ, 08033

856-433-1500

SEC Filing

0001752026-24-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Linnaeus Therapeutics, Inc. Form D Filing — $6,860,000 | FilingFlow